Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Oct 21;13(11):3697.
doi: 10.3390/nu13113697.

Time-Limited Eating and Continuous Glucose Monitoring in Adolescents with Obesity: A Pilot Study

Alaina P Vidmar  1   2 , Monica Naguib  1   2 , Jennifer K Raymond  1   2 , Sarah Jeanne Salvy  3 , Elizabeth Hegedus  1   2 , Choo Phei Wee  4 , Michael I Goran  1   2
Affiliations
Randomized Controlled Trial

Time-Limited Eating and Continuous Glucose Monitoring in Adolescents with Obesity: A Pilot Study

Alaina P Vidmar et al. Nutrients. .

Abstract

Due to its simplicity, time-limited eating (TLE) may represent a more feasible approach for treating adolescents with obesity compared to other caloric restriction regimens. This pilot study examines the feasibility and safety of TLE combined with continuous glucose monitoring (CGM) in adolescents. Fifty adolescents with BMI ≥95th percentile were recruited to complete a 12-week study. All received standard nutritional counseling, wore a CGM daily, and were randomized to: (1) Prolonged eating window: 12 h eating/12 h fasting + blinded CGM; (2) TLE (8 h eating/16 h fasting, 5 days per week) + blinded CGM; (3) TLE + real-time CGM feedback. Recruitment, retention, and adherence were recorded as indicators of feasibility. Weight loss, dietary intake, physical activity, eating behaviors, and quality of life over the course of the intervention were explored as secondary outcomes. Forty-five participants completed the study (16.4 ± 1.3 years, 64% female, 49% Hispanic, 75% public insurance). There was high adherence to prescribed eating windows (TLE 5.2 d/wk [SD 1.1]; control 6.1 d/wk [SD 1.4]) and daily CGM wear (5.85 d/wk [SD 4.8]). Most of the adolescents (90%) assigned to TLE reported that limiting their eating window and wearing a CGM was feasible without negative impact on daily functioning or adverse events. There were no between-group difference in terms of weight loss, energy intake, quality of life, physical activity, or eating behaviors. TLE combined with CGM appears feasible and safe among adolescents with obesity. Further investigation in larger samples, with a longer intervention duration and follow-up assessments are needed.

Keywords: adolescents; continuous glucose monitor; intermittent fasting; obesity; pediatrics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Consolidated Standards of Reporting Trials (CONSORT) flow diagram of participant inclusions.
Figure 2
Figure 2
Percent weight loss at week 12 compared to baseline by individual participants across: (a) all three intervention arms and (b) TLE groups (TLE + blinded CGM and TLE + real-time CGM) compared to control.
Figure 3
Figure 3
Weight change across the study period by intervention group for (a) change in excess percent of the 95th percentile (%BMIp95) and (b) change in BMI z-score.
See this image and copyright information in PMC

References

    1. Copeland K.C., Zeitler P., Geffner M., Guandalini C., Higgins J., Hirst K., Kaufman F.R., Linder B., Marcovina S., McGuigan P., et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J. Clin. Endocrinol. Metab. 2011;96:159–167. doi: 10.1210/jc.2010-1642. - DOI - PMC - PubMed
    1. Marcus M.D., Wilfley D.E., El Ghormli L., Zeitler P., Linder B., Hirst K., Ievers-Landis C.E., van Buren D.J., Walders-Abramson N., TODAY Study Group Weight change in the management of youth-onset type 2 diabetes: The TODAY clinical trial experience. Pediatr. Obes. 2017;12:337–345. doi: 10.1111/ijpo.12148. - DOI - PMC - PubMed
    1. Kumar S., Kelly A.S. Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. Mayo Clin. Proc. 2017;92:251–265. doi: 10.1016/j.mayocp.2016.09.017. - DOI - PubMed
    1. August G.P., Caprio S., Fennoy I., Freemark M., Kaufman F.R., Lustig R.H., Silverstein J.H., Speiser P.W., Styne D.M., Montori V.M. Prevention and treatment of pediatric obesity: An Endocrine Society clinical practice guideline based on expert opinion. J. Clin. Endocrinol. Metab. 2008;93:4576–4599. doi: 10.1210/jc.2007-2458. - DOI - PMC - PubMed
    1. Cardel M.I., Atkinson M.A., Taveras E.M., Holm J.C., Kelly A.S. Obesity Treatment among Adolescents: A Review of Current Evidence and Future Directions. JAMA Pediatr. 2020;174:609–617. doi: 10.1001/jamapediatrics.2020.0085. - DOI - PMC - PubMed

Publication types

LinkOut - more resources